Apr 2014 $7 M No. 5 $2 to $10 million 10
Sorbent Therapeutics Inc: Raise no. 5, Apr 2014 × Investors in this round 10 investors had bought by the notice of May 15, 2014: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $15 M offered; $9 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Detlef Albrecht · Executive Officer, Director Howard C. Dittrich · Executive Officer Jason P. Levin · Executive Officer Linda C. De Young · Executive Officer Thomas P. O'Neil · Executive Officer David Collier · Director Donald Joseph · Director James Healy · Director Marcus Goebel · Director Randall Woods · Director Scott Minick · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Thomas P. O'Neil, Chief Financial Officer. Source: SEC Form D, newest notice filed May 15, 2014. Read the notice at the SEC .
equity SEC Jul 2012 $18 M No. 4 $10 to $50 million 10
Sorbent Therapeutics Inc: Raise no. 4, Jul 2012 × Investors in this round 10 investors had bought by the notice of Aug 8, 2012: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $18 M of $24 M offered; $6 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Detlef Albrecht · Executive Officer, Director Linda Ara · Executive Officer Linda De Young · Executive Officer David Collier · Director Donald Joseph · Director James Healy · Director Markus Goebel · Director Randall Woods · Director Scott Minick · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The exact amount of the total offering is $24,056,217.68, the exact amount of the total sold is $18,056,217.86 and the exact amount of the total remaining to be sold is $5,999,999.94.”Signed by Linda Ara, Cfo. Source: SEC Form D, newest notice filed Aug 8, 2012. Read the notice at the SEC .
equity SEC May 2012 $6 M No. 3 $2 to $10 million 10
Sorbent Therapeutics Inc: Raise no. 3, May 2012 × Investors in this round 10 investors had bought by the notice of Jun 8, 2012: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Detlef Albrecht · Executive Officer, Director Linda Ara · Executive Officer Linda De Young · Executive Officer David Collier · Director Donald Joseph · Director James Healy · Director Marcus Goebel · Director Randall Woods · Director Scott Minick · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Linda Ara, Cfo. Source: SEC Form D, newest notice filed Jun 8, 2012. Read the notice at the SEC .
debt, options SEC Jun 2011 $11 M No. 2 $10 to $50 million 10
Sorbent Therapeutics Inc: Raise no. 2, Jun 2011 × Investors in this round 10 investors had bought by the notice of Jun 16, 2011: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $11 M of $36 M offered; $25 M still to sell
Smallest investment taken no minimum stated
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Detlef Albrecht · Executive Officer, Director Linda Ara · Executive Officer Linda De Young · Executive Officer David Collier · Director Donald Joseph · Director James Healy · Director Markus Goebel · Director Scott Minick · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Funds to be used for working capital.”Signed by Linda Ara, Treasurer. Source: SEC Form D, newest notice filed Jun 16, 2011. Read the notice at the SEC .
equity SEC Jun 2010 $17 M No. 1 $10 to $50 million 10
Sorbent Therapeutics Inc: Raise no. 1, Jun 2010 × Investors in this round 10 investors had bought by the notice of Jul 14, 2010: 10 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $17 M of $22 M offered; $5 M still to sell
Smallest investment taken $47,511
What was sold equity
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people $500,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Donald Joseph · Executive Officer, Director · Director, President and CEO William I. Rajski · Executive Officer · Chief Financial Officer, Treasurer and Secretary David I. Collier · Director James I. Healy · Director Scott Minick · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Portions of the proceeds will be used to pay the executive officers' annual compensation in the ordinary course of business.”Signed by William Rajski, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 14, 2010. Read the notice at the SEC .
equity SEC